Spermosens AB (publ) (NGM:SPERM)
0.0092
+0.0002 (2.22%)
At close: Mar 9, 2026
Spermosens AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 6.84 | 0.66 | 4.49 | 0.55 | 6.69 | Upgrade
|
| Cash & Short-Term Investments | 6.84 | 0.66 | 4.49 | 0.55 | 6.69 | Upgrade
|
| Cash Growth | 937.33% | -85.33% | 713.77% | -91.75% | 80.35% | Upgrade
|
| Other Receivables | 0.97 | 1.09 | 0.99 | 0.56 | 0.61 | Upgrade
|
| Receivables | 0.97 | 1.09 | 0.99 | 0.56 | 0.61 | Upgrade
|
| Prepaid Expenses | - | 0.01 | 0.23 | 0.26 | 0.09 | Upgrade
|
| Total Current Assets | 7.8 | 1.76 | 5.72 | 1.37 | 7.4 | Upgrade
|
| Property, Plant & Equipment | 0.32 | 0.46 | 0.65 | 0.71 | - | Upgrade
|
| Long-Term Deferred Charges | 25.82 | 24.34 | 19.74 | 7.58 | 18.28 | Upgrade
|
| Other Long-Term Assets | - | 4.49 | - | - | - | Upgrade
|
| Total Assets | 33.94 | 31.04 | 26.11 | 9.66 | 25.68 | Upgrade
|
| Accounts Payable | 0.13 | 2.02 | 1.34 | 0.74 | 0.48 | Upgrade
|
| Accrued Expenses | - | 0.78 | 1.44 | 1.23 | 0.73 | Upgrade
|
| Short-Term Debt | - | 0.23 | 9.29 | 0.13 | 0.13 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.18 | Upgrade
|
| Other Current Liabilities | - | 0.67 | 1.12 | 0.51 | 0.16 | Upgrade
|
| Total Current Liabilities | 0.13 | 3.7 | 13.18 | 2.6 | 1.68 | Upgrade
|
| Long-Term Debt | - | - | 0.23 | 1.24 | 0.37 | Upgrade
|
| Other Long-Term Liabilities | 1.4 | -0 | - | - | - | Upgrade
|
| Total Liabilities | 1.53 | 3.7 | 13.41 | 3.84 | 2.04 | Upgrade
|
| Common Stock | 6.35 | 1.52 | 4.12 | 1.21 | 1.05 | Upgrade
|
| Additional Paid-In Capital | - | 92.17 | 65.61 | 49.45 | 31.04 | Upgrade
|
| Retained Earnings | - | -67.24 | -57.03 | -44.83 | -8.45 | Upgrade
|
| Comprehensive Income & Other | 26.06 | 0.9 | - | - | - | Upgrade
|
| Shareholders' Equity | 32.41 | 27.35 | 12.69 | 5.83 | 23.64 | Upgrade
|
| Total Liabilities & Equity | 33.94 | 31.04 | 26.11 | 9.66 | 25.68 | Upgrade
|
| Total Debt | - | 0.23 | 9.52 | 1.36 | 0.49 | Upgrade
|
| Net Cash (Debt) | 6.84 | 0.43 | -5.03 | -0.81 | 6.2 | Upgrade
|
| Net Cash Growth | 1493.47% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | -0.13 | -0.07 | 0.70 | Upgrade
|
| Filing Date Shares Outstanding | 3,172 | 283.61 | 41.19 | 12.12 | 10.51 | Upgrade
|
| Total Common Shares Outstanding | 3,172 | 283.61 | 41.19 | 12.12 | 10.51 | Upgrade
|
| Working Capital | 7.68 | -1.94 | -7.47 | -1.23 | 5.72 | Upgrade
|
| Book Value Per Share | 0.01 | 0.10 | 0.31 | 0.48 | 2.25 | Upgrade
|
| Tangible Book Value | 32.41 | 27.35 | 12.69 | 5.83 | 23.64 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.10 | 0.31 | 0.48 | 2.25 | Upgrade
|
| Machinery | - | 0.86 | 0.89 | 0.78 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.